Chemical Compound

Lazertinib; 2-Propenamide, N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-4-methoxy-2-(4-morpholinyl)phenyl]- (ACI); N-[5-[[4-[4-[(Dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-4-methoxy-2-(4-morpholinyl)phen

CAS Registry Number 1903008-80-9
返回搜索 申请报价
Lazertinib; 2-Propenamide, N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-4-methoxy-2-(4-morpholinyl)phenyl]- (ACI); N-[5-[[4-[4-[(Dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-4-methoxy-2-(4-morpholinyl)phen 结构式
Primary record

Lazertinib; 2-Propenamide, N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-4-methoxy-2-(4-morpholinyl)phenyl]- (ACI); N-[5-[[4-[4-[(Dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-4-methoxy-2-(4-morpholinyl)phen

库存
4,397 克
纯度
99.4 %
CAS
1903008-80-9

化合物标识与属性

CAS
1903008-80-9
PubChem CID
121269225
SMILES
CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC
Canonical SMILES
C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1

名称与同义词

  • Lazertinib
  • Lazcluze
  • lazertinibum
  • Leclaza
  • 1903008-80-9
  • Lazertinib?
  • Lazertinib [USAN]
  • Lazertinib [INN]
  • GNS1480
  • GNS-1480
  • LAZERTINIB [INN]
  • Lazertinib (USAN/INN)
  • Lazertinib [USAN:INN]
  • RefChem:798668
  • JNJ-73841937-AAA
  • YH-25448
  • YH25448
  • 4A2Y23XK11
  • LAZERTINIB [WHO-DD]
  • UNII-4A2Y23XK11
  • orb1689983
  • CHEMBL4558324
  • SCHEMBL17670400
  • GTPL10136
  • RRMJMHOQSALEJJ-UHFFFAOYSA-N
  • C-18112003-G
  • C30H34N8O3
  • DTXSID601376595
  • GLXC-21722
  • BCP30440
  • DBD00880
  • EX-A1912
  • BDBM50555575
  • MFCD31728331
  • s8724
  • WHO 10587
  • AKOS037515597
  • CCG-270023
  • Lazertinib (YH25448,GNS-1480)
  • YH-25448;GNS-1480
  • AC-36243
  • BP-43658
  • BS-15742
  • DA-74916
  • YH 25448
  • Compound 73 [WO2016060443A2]
  • HY-109061
  • AK00779508
  • CS-0032992
  • J3.766.889C
  • N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholinophenyl)acrylamide
  • A16827
  • D11980
  • A903188
  • N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide
  • 2-Propenamide, N-(5-((4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)-
  • B0084-267741
  • N-{5-[(4-{4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl}pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl}prop-2-enamide
  • YH-25448; YH 25448; YH25448; GNS-1480; GNS 1480; GNS1480
  • Lazertinib; 2-Propenamide, N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-4-methoxy-2-(4-morpholinyl)phenyl]- (ACI); N-[5-[[4-[4-[(Dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-4-methoxy-2-(4-morpholinyl)phen
  • N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)acrylamide
  • N-(5-((4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-(morpholin-4-yl)phenyl)prop-2-enamide
  • N-(5-((4-(4-((dimethylamino)methyl)-3-phenylpyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholin-4-ylphenyl)prop-2-enamide
  • N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide
  • N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenyl-pyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholino-phenyl]prop-2-enamide
  • N-{5-[(4-{4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl}pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl}prop-2-enamide
  • N-5-[[4-[4-[(Dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholinophenyl]acrylamide